| 1 |
31770573 | Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate. | 2020 Jan 10 |
7 |
| 2 |
25729581 | Characterizing the binding interactions between P-glycoprotein and eight known cardiovascular transport substrates. | 2015 Mar |
1 |
| 3 |
23204072 | The use of microdialysis techniques in mice to study P-gp function at the blood-brain barrier. | 2013 Apr |
3 |
| 4 |
23777437 | In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study. | 2013 Nov |
7 |
| 5 |
21934030 | Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate. | 2011 Dec |
1 |
| 6 |
17683917 | A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. | 2008 Mar |
1 |
| 7 |
16931690 | The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition. | 2006 Sep |
1 |
| 8 |
12721332 | Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampin. | 2003 Aug |
2 |
| 9 |
11489261 | Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | 2001 Aug 10 |
2 |
| 10 |
11496955 | Effect of mdr1a P-glycoprotein gene disruption, gender, and substrate concentration on brain uptake of selected compounds. | 2001 Jul |
4 |
| 11 |
7983045 | Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport. | 1994 Dec 9 |
2 |